Merus N.v. buy BiotechBee
Start price
24.06.23
/
70%
€23.20
Target price
30.04.26
€40.00
Performance (%)
95.69%
Price
18:25
€48.20
Summary
This prediction is currently active. With a performance of 95.69% the BUY prediction by BiotechBee is a big success. This prediction currently runs until 30.04.26. The prediction end date can be changed by BiotechBee at any time. BiotechBee has 70% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Merus N.v. | - | - | - |
iShares Core DAX® | -1.114% | 5.062% | 24.922% |
iShares Nasdaq 100 | 1.816% | 9.828% | 29.548% |
iShares Nikkei 225® | 2.113% | 8.218% | 22.231% |
iShares S&P 500 | 2.038% | 7.448% | 30.358% |
According to BiotechBee what are the pros and cons of Merus N.v. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Merus N.v. diskutieren
Buy mit Kursziel 40,0